“The Ozempic Revolution” by Alexandra Sowa
I was sent a review copy of this book by HarperCollins India. It made me curious about the Ozempic drug. Suddenly, news about it was visible everywhere. I am a little sceptical about it since it is a chemical composition that is ostensibly for diabetics but is increasingly being used to fight obesity. It has made the Danish company, Novo Nordisk, one of the richest companies globally, not just in pharmaceutical. It is worth more than half a trillion dollars at present and growing, day by day. Ozempic has become so popular that there is always a short supply of this drug in the market. As a result, other pharma companies are creating the drug and marketing it. The Australian government is trying to regulate the use of this drug while recognising its benefits. Other countries are also beginning to document the lesser known side effects of this drug such as gastric disorders and pancreatis. There have been some instances of blindness and deaths linked to the use of Ozempic too but in a small number so as to not mar the popular use as well as recommendation by doctors of the drug. Novo Nordisk is aware of these deaths. Even in India there are discussions about it, with doctors advising its use with caution.
Ozempic, as a diabetes drug, was first launched in the market in 2017, after nearly two decades of research. When its impact on obesity was noticed, then four years later, in 2021, Wegovy ( the brand name) was launched.
Watch this video about the scientist behind this discovery:
While Ozempic has become a roaring success primarily because it fights obesity, but it has also proven to be a profitable venture for Novo Nordisk, it now has a fair share of its critics as well. In July 2025, a lawsuit was filed in the USA. Nevertheless, despite advertisements for medicines not being permitted by law in Denmark, some have been created and posted (here and here). Most likely in a different land but social media ensures that these advertisements are visible across the world.
Here is the book blurb of The Ozempic Revolution. I am sharing it as it is. It is very upbeat and positive about the impact of the drug. Most likely, it is useful for millions but even so, the dangerous side effects cannot be ignored.
The newest class of weight loss drugs (GLP-1s) are complete game-changers in their potential to reverse obesity and its related diseases, with nearly 50% of Americans qualifying for the use of these drugs. Already 1 in 8 Americans say they’ve tried a GLP-1 medication—but with many acquiring their prescription from online pharmacies, med spas, and general practitioners, they face a huge gap between trying the drug and achieving their health goals with it long-term.
That’s where The Ozempic Revolution comes in. Dr. Alexandra Sowa, a leading obesity medicine specialist, will share her expertise on this much-discussed but largely misunderstood class of medications. Traditional and social media has been flooded with junk information and stigmatizing headlines about GLP-1s, and in this book Dr. Sowa digs into all of it—the good, the bad, and the ugly—bringing the science to light.
Having helped thousands of patients achieve weight health, Dr. Sowa knows that obesity is a complex disease. Few doctors are equipped to provide guidance on the mix of issues, both physical and emotional, that can complicate maintaining a healthy weight. A pioneer in the use of GLP-1s, Dr. Sowa emphasizes that they’re not a silver bullet, and this book takes a comprehensive approach by recommending diet and lifestyle interventions that help people stay safe and feel great while on these drugs, especially during the period when their bodies are adjusting. Using the book’s unique nonrestrictive food plans and strategies for managing the mental health challenges of losing weight, readers will learn how to push through old behaviors and beliefs so these new medications can do their jobs.
This clear-eyed, fully informed approach to GLP-1s will help anyone who is considering them make the right decision, and guarantee success for anyone taking them by helping them not only lose the weight but keep it off for good.
Dr. Alexandra Sowa is a trailblazer in obesity medicine, known for her unique blend of scientific rigor and thoughtful patient advocacy. Her dual certification in internal medicine and obesity medicine, along with her role as a clinical instructor at NYU School of Medicine, sets her apart as an expert deeply committed to advancing treatment paradigms. Through SoWell Health, she extends her reach beyond the clinic, offering innovative telehealth services and resources that reflect her philosophy of care—holistic, evidence-based, and deeply respectful of the emotional dimensions of health. A frequent contributor to major publications including The New York Times and The Atlantic and a regular expert on national broadcasts, Dr. Sowa educates on the complexities of obesity with clarity and compassion.
Be informed. Be safe.
20 July 2025



